GERON CORP Stock-Based Compensation
GERON CORP (GERN) reported Stock-Based Compensation of $9.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- GERON CORP share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.95M, a 26.83% decline year-over-year.
- GERON CORP share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $4.91M, a 33.81% decline year-over-year.
- GERON CORP share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.77M, a 15.04% decline year-over-year.
- GERON CORP share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $6.70M, a 2.74% decline year-over-year.
- GERON CORP share-based payment arrangement, noncash expense for fiscal 2025 was $26.66M, a 14.51% decline from fiscal 2024.
- GERON CORP share-based payment arrangement, noncash expense for fiscal 2024 was $31.18M, a 68.33% increase from fiscal 2023.
- GERON CORP share-based payment arrangement, noncash expense for fiscal 2023 was $18.53M, a 131.55% increase from fiscal 2022.
- GERON CORP share-based payment arrangement, noncash expense for fiscal 2022 was $8.00M, a 0.98% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $9.86M 10-Q · filed 2026-08-05 | $15.63M derived: sum of 3 quarters · filed 2026-08-05 | $22.33M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $4.91M 10-Q · filed 2026-05-06 | $10.68M derived: sum of 2 quarters · filed 2026-05-06 | $17.39M derived: sum of 3 quarters · filed 2026-05-06 | $24.15M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $5.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $12.47M derived: sum of 2 quarters · filed 2026-03-02 | $19.24M derived: sum of 3 quarters · filed 2026-08-05 | $26.66M 10-K · filed 2026-03-02 | ||
| 2025-09-30 | $6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $13.46M derived: sum of 2 quarters · filed 2026-08-05 | $20.89M 10-Q · filed 2025-11-07 | $27.68M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $6.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $14.19M 10-Q · filed 2026-08-05 | $14.15M 10-Q · filed 2025-08-06 | $20.98M derived: sum of 3 quarters · filed 2026-08-05 | $27.87M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $7.42M 10-Q · filed 2026-05-06 | $7.41M 10-Q · filed 2025-05-07 | $14.22M derived: sum of 2 quarters · filed 2026-05-06 | $21.11M derived: sum of 3 quarters · filed 2026-05-06 | $33.73M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $6.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $13.68M derived: sum of 2 quarters · filed 2026-03-02 | $26.31M derived: sum of 3 quarters · filed 2026-03-02 | $31.18M 10-K · filed 2026-03-02 | ||
| 2024-09-30 | $6.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $19.52M derived: sum of 2 quarters · filed 2025-11-07 | $24.39M 10-Q · filed 2025-11-07 | $28.81M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-06-30 | $12.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $17.50M 10-Q · filed 2025-08-06 | $21.92M derived: sum of 3 quarters · filed 2026-03-02 | $29.12M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-03-31 | $4.88M 10-Q · filed 2025-05-07 | $9.29M derived: sum of 2 quarters · filed 2026-03-02 | $16.50M derived: sum of 3 quarters · filed 2026-03-02 | $20.44M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2023-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $11.62M derived: sum of 2 quarters · filed 2026-03-02 | $15.56M derived: sum of 3 quarters · filed 2026-03-02 | $18.53M 10-K · filed 2026-03-02 | ||
| 2023-09-30 | $7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $11.15M derived: sum of 2 quarters · filed 2024-11-07 | $14.11M 10-Q · filed 2024-11-07 | $16.30M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.91M 10-Q · filed 2024-08-08 | $9.09M derived: sum of 3 quarters · filed 2025-02-27 | $11.16M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $2.96M 10-Q · filed 2024-05-02 | $5.15M derived: sum of 2 quarters · filed 2025-02-27 | $7.21M derived: sum of 3 quarters · filed 2025-02-27 | $9.27M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.25M derived: sum of 2 quarters · filed 2025-02-27 | $6.31M derived: sum of 3 quarters · filed 2025-02-27 | $8.00M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $4.12M derived: sum of 2 quarters · filed 2023-11-02 | $5.81M 10-Q · filed 2023-11-02 | $8.12M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.75M 10-Q · filed 2023-08-03 | $6.05M derived: sum of 3 quarters · filed 2024-02-28 | $8.06M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $1.69M 10-Q · filed 2023-05-11 | $4.00M derived: sum of 2 quarters · filed 2024-02-28 | $6.00M derived: sum of 3 quarters · filed 2024-02-28 | $7.98M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $4.31M derived: sum of 2 quarters · filed 2024-02-28 | $6.29M derived: sum of 3 quarters · filed 2024-02-28 | $8.08M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $3.98M derived: sum of 2 quarters · filed 2022-11-07 | $5.78M 10-Q · filed 2022-11-07 | $7.63M derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2021-06-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.77M 10-Q · filed 2022-08-11 | $5.62M derived: sum of 3 quarters · filed 2023-03-16 | $7.39M derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2021-03-31 | $1.79M 10-Q · filed 2022-05-09 | $3.65M derived: sum of 2 quarters · filed 2023-03-16 | $5.41M derived: sum of 3 quarters · filed 2023-03-16 | $7.12M derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.62M derived: sum of 2 quarters · filed 2023-03-16 | $5.33M derived: sum of 3 quarters · filed 2023-03-16 | $6.89M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.48M derived: sum of 2 quarters · filed 2021-11-09 | $5.04M 10-Q · filed 2021-11-09 | $6.69M derived: sum of 4 quarters · filed 2022-03-10 | ||
| 2020-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $3.27M 10-Q · filed 2021-08-16 | $4.92M derived: sum of 3 quarters · filed 2022-03-10 | $6.49M derived: sum of 4 quarters · filed 2022-03-10 | ||
| 2020-03-31 | $1.57M 10-Q · filed 2021-05-10 | $3.22M derived: sum of 2 quarters · filed 2022-03-10 | $4.79M derived: sum of 3 quarters · filed 2022-03-10 | $6.22M derived: sum of 4 quarters · filed 2022-03-10 | ||
| 2019-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $3.22M derived: sum of 2 quarters · filed 2022-03-10 | $4.65M derived: sum of 3 quarters · filed 2022-03-10 | $6.08M 10-K · filed 2022-03-10 | ||
| 2019-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.00M derived: sum of 2 quarters · filed 2020-11-05 | $4.43M 10-Q · filed 2020-11-05 | $6.02M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.86M 10-Q · filed 2020-08-06 | $4.45M derived: sum of 3 quarters · filed 2021-03-11 | $6.07M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-03-31 | $1.43M 10-Q · filed 2020-05-28 | $3.02M derived: sum of 2 quarters · filed 2021-03-11 | $4.63M derived: sum of 3 quarters · filed 2021-03-11 | $6.18M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2018-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $3.21M derived: sum of 2 quarters · filed 2021-03-11 | $4.75M derived: sum of 3 quarters · filed 2021-03-11 | $6.37M 10-K · filed 2021-03-11 | ||
| 2018-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $3.16M derived: sum of 2 quarters · filed 2019-11-06 | $4.77M 10-Q · filed 2019-11-06 | $6.77M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-06-30 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $3.16M 10-Q · filed 2019-08-01 | $5.15M derived: sum of 3 quarters · filed 2020-03-12 | $7.25M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-03-31 | $1.61M 10-Q · filed 2019-05-02 | $3.61M derived: sum of 2 quarters · filed 2020-03-12 | $5.70M derived: sum of 3 quarters · filed 2020-03-12 | $7.78M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2017-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $4.09M derived: sum of 2 quarters · filed 2020-03-12 | $6.16M derived: sum of 3 quarters · filed 2020-03-12 | $8.14M 10-K · filed 2020-03-12 | ||
| 2017-09-30 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $4.17M derived: sum of 2 quarters · filed 2018-11-01 | $6.15M 10-Q · filed 2018-11-01 | $8.13M derived: sum of 4 quarters · filed 2019-03-07 | ||
| 2017-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $4.06M 10-Q · filed 2018-07-31 | $6.04M derived: sum of 3 quarters · filed 2019-03-07 | $8.17M derived: sum of 4 quarters · filed 2019-03-07 | ||
| 2017-03-31 | $1.98M 10-Q · filed 2018-05-10 | $3.96M derived: sum of 2 quarters · filed 2019-03-07 | $6.09M derived: sum of 3 quarters · filed 2019-03-07 | $8.21M derived: sum of 4 quarters · filed 2019-03-07 | ||
| 2016-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $4.11M derived: sum of 2 quarters · filed 2019-03-07 | $6.23M derived: sum of 3 quarters · filed 2019-03-07 | $8.24M 10-K · filed 2019-03-07 | ||
| 2016-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $4.24M derived: sum of 2 quarters · filed 2017-11-01 | $6.26M 10-Q · filed 2017-11-01 | $8.21M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-06-30 | $2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $4.14M 10-Q · filed 2017-08-09 | $6.08M derived: sum of 3 quarters · filed 2018-03-16 | $8.14M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-03-31 | $2.02M 10-Q · filed 2017-05-09 | $3.96M derived: sum of 2 quarters · filed 2018-03-16 | $6.03M derived: sum of 3 quarters · filed 2018-03-16 | $8.40M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2015-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $4.01M derived: sum of 2 quarters · filed 2018-03-16 | $6.38M derived: sum of 3 quarters · filed 2018-03-16 | $8.40M 10-K · filed 2018-03-16 | ||
| 2015-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.44M derived: sum of 2 quarters · filed 2016-11-03 | $6.45M 10-Q · filed 2016-11-03 | $8.36M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $4.39M 10-Q · filed 2016-08-03 | $6.29M derived: sum of 3 quarters · filed 2017-03-01 | $8.30M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $2.01M 10-Q · filed 2016-05-05 | $3.92M derived: sum of 2 quarters · filed 2017-03-01 | $5.93M derived: sum of 3 quarters · filed 2017-03-01 | $8.03M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.92M derived: sum of 2 quarters · filed 2017-03-01 | $6.02M derived: sum of 3 quarters · filed 2017-03-01 | $7.66M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $4.11M derived: sum of 2 quarters · filed 2015-11-05 | $5.75M 10-Q · filed 2015-11-05 | $6.73M derived: sum of 4 quarters · filed 2016-03-10 | ||
| 2014-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $3.74M 10-Q · filed 2015-08-05 | $4.72M derived: sum of 3 quarters · filed 2016-03-10 | $5.94M derived: sum of 4 quarters · filed 2016-03-10 | ||
| 2014-03-31 | $1.64M 10-Q · filed 2015-05-07 | $2.62M derived: sum of 2 quarters · filed 2016-03-10 | $3.84M derived: sum of 3 quarters · filed 2016-03-10 | $4.73M derived: sum of 4 quarters · filed 2016-03-10 | ||
| 2013-12-31 | $979.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $2.20M derived: sum of 2 quarters · filed 2016-03-10 | $3.09M derived: sum of 3 quarters · filed 2016-03-10 | $4.43M 10-K · filed 2016-03-10 | ||
| 2013-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $2.11M derived: sum of 2 quarters · filed 2014-11-05 | $3.46M 10-Q · filed 2014-11-05 | $4.75M derived: sum of 4 quarters · filed 2015-03-11 | ||
| 2013-06-30 | $886.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $2.23M 10-Q · filed 2014-08-11 | $3.53M derived: sum of 3 quarters · filed 2015-03-11 | $4.79M derived: sum of 4 quarters · filed 2015-03-11 | ||
| 2013-03-31 | $1.35M 10-Q · filed 2014-05-01 | $2.64M derived: sum of 2 quarters · filed 2015-03-11 | $3.91M derived: sum of 3 quarters · filed 2015-03-11 | $5.27M derived: sum of 4 quarters · filed 2015-03-11 | ||
| 2012-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $2.56M derived: sum of 2 quarters · filed 2015-03-11 | $3.92M derived: sum of 3 quarters · filed 2015-03-11 | $5.31M 10-K · filed 2015-03-11 | ||
| 2012-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.63M derived: sum of 2 quarters · filed 2013-11-07 | $4.02M 10-Q · filed 2013-11-07 | $6.73M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.75M 10-Q · filed 2013-08-08 | $5.47M derived: sum of 3 quarters · filed 2014-03-17 | $7.84M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | $1.39M 10-Q · filed 2013-05-03 | $4.11M derived: sum of 2 quarters · filed 2014-03-17 | $6.47M derived: sum of 3 quarters · filed 2014-03-17 | $10.32M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2011-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $5.08M derived: sum of 2 quarters · filed 2014-03-17 | $8.93M derived: sum of 3 quarters · filed 2014-03-17 | $15.25M 10-K · filed 2014-03-17 | ||
| 2011-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $6.21M derived: sum of 2 quarters · filed 2012-11-02 | $12.53M 10-Q · filed 2012-11-02 | $15.81M derived: sum of 4 quarters · filed 2013-03-15 | ||
| 2011-06-30 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $10.17M 10-Q · filed 2012-08-03 | $13.44M derived: sum of 3 quarters · filed 2013-03-15 | $17.76M derived: sum of 4 quarters · filed 2013-03-15 | ||
| 2011-03-31 | $6.32M 10-Q · filed 2012-05-07 | $9.60M derived: sum of 2 quarters · filed 2013-03-15 | $13.92M derived: sum of 3 quarters · filed 2013-03-15 | |||
| 2010-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $7.60M derived: sum of 2 quarters · filed 2013-03-15 | $13.72M 10-K · filed 2013-03-15 | |||
| 2010-09-30 | $4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $10.44M 10-Q · filed 2011-11-03 | ||||
| 2010-06-30 | $6.12M 10-Q · filed 2011-08-05 | |||||
| 2009-12-31 | $10.57M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |